No vague advice
The choice is dictated by client preference, the reason for the deficiency, and the tolerance to a given supplement
The animals were group-housed until one week before treatment initiation, after which they were given daily subcutaneous injections of vehicle or Cagrilintide at doses of 0.3, 3, or 30 nmol/kg for 21 days
(All committee members underwent the same ethics review and vetting process required of all FDA advisory committee members, Emily Hilliard, a spokesperson for the Department of Health and Human Services, told me in an email.) The decision is only a recommendation, and the FDA would still need to sign off on an actual rule change
In a medical clinic like ours, BPC-157 is delivered two clinically relevant ways: subcutaneous injection and, in selected gut-specific cases, oral capsules